Enhanced by OneKey, the Customer Relationship Management (CRM) solution will enable the company to maintain better relationships with stakeholders. The Mobile Intelligence solution provides better governance through deeper
Otsuka Pharmaceutical, which has licensed the US commercialization rights to the product, will fund the clinical program. GW R&D director Stephen Wright said, "This clinical development programme, being
The omega-3 fish oil nutritional supplement is thought to have higher bioavailability than ordinary fish oils. Jarrow Formulas marketing director Rory Lipsky said, "PhosphOmega provides omega-3s in both
RayBiotech will leverage its antibody array diagnostics technologies to collect quantitative diagnostics information concerning key biochemical targets involved in human physiology and disease. RayBiotech president COO and co-founder
The product monograph change will help enable individual benefit risk assessment for MS patients. The new label identifies anti-JCV antibody status as a risk factor for developing an
The antibacterial oxazolidinone targets infections due to multi-drug resistant Gram-positive pathogens. MicuRx president and chief executive officer Zhengyu Yuan said, "With a scarcity of new antibiotics in development
The new release includes more than 94,500 gene entries, displays about 52,000 non-protein-coding RNA genes and also shows considerably expanded tissue proteome abundance diagrams. LifeMap Sciences president and
The company has even filed an application with European marketing authorization for regorafenib for the treatment of patients with mCRC. The submission is based on the results of
The company plans to expand the product category with antibodies against Alemtuzumab (Campath), Bevacizumab (Avastin), Infliximab (Remicade), Ustekinumab (Stelara) and Adalimumab (Humira) shortly. AbD Serotec head Dieter Feger
The company has launched Suprenza ODT in 15mg and 30mg dosage strengths. Suprenza is a sympathomimetic amine anorectic indicated for patients with an initial body mass index of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.